Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03067818 · ClinicalTrials.gov registry record · NA
Mechanisms of Arm Recovery in Stroke Patients With Hand Paralysis
A NA study of Stroke and Stroke, Ischemic, sponsored by George Mason University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT03067818: Completed NA study of Stroke and Stroke, Ischemic, sponsored by George Mason University.
NCT03067818 is a NA study of Stroke and Stroke, Ischemic that has completed, run by George Mason University. The registered enrollment target is 10 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03067818, a NA study of Stroke and Stroke, Ischemic, has completed, sponsored by George Mason University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This study examines the effect of non-invasive brain stimulation targeting different brain areas on movement of the affected arm post-stroke. Participants will receive stimulation to each of 3 different brain areas combined with a session of arm exercise.
Primary Outcome
Percentage change in time it takes to move the arm a standardized distance
Conditions Studied
Interventions
- PROCEDURE Unaffected Transcranial Magnetic Stimulation
- PROCEDURE Affected Transcranial Magnetic Stimulation
- PROCEDURE Control Transcranial Magnetic Stimulation
Study Locations (1)
District of Columbia
- MedStar National Rehabilitation Hospital - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-06-20 |
| Est. Completion | 2019-08-28 |
| Phase | NA |
What the finished NCT03067818 record still lists
NCT03067818 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).
The record links to 4 conditions, with Stroke appearing as the primary indexed condition, and to 3 interventions - of which Unaffected Transcranial Magnetic Stimulation is the first listed.
NCT03067818 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT03067818 about?
NCT03067818 is a clinical study titled "Mechanisms of Arm Recovery in Stroke Patients With Hand Paralysis". This study examines the effect of non-invasive brain stimulation targeting different brain areas on movement of the affected arm post-stroke. Participants will receive stimulation to each of 3 different brain areas combined with a session of arm exercise.
What is the current status of trial NCT03067818?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2017-06-20. Estimated completion is 2019-08-28.
What conditions does trial NCT03067818 study?
This clinical trial studies the following conditions: Stroke, Stroke, Ischemic, Hemiparesis, Cerebral Vascular Accident.
What interventions are being tested in trial NCT03067818?
The interventions under investigation include: Unaffected Transcranial Magnetic Stimulation (PROCEDURE), Affected Transcranial Magnetic Stimulation (PROCEDURE), Control Transcranial Magnetic Stimulation (PROCEDURE).
Who is sponsoring clinical trial NCT03067818?
This trial is sponsored by George Mason University, which has 25 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03067818 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03067818's enrollment target sits among peer trials
10 415th of 454 higher than 30 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
- NCT01870752 · 10 participants · NA
Ovarian Tissue Transplantation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI